Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001800009 | SCV002044076 | uncertain significance | not provided | 2021-12-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Labcorp Genetics |
RCV001800009 | SCV002437704 | benign | not provided | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002343860 | SCV002652706 | likely benign | Cardiovascular phenotype | 2024-06-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
New York Genome Center | RCV002468316 | SCV002764413 | uncertain significance | Hypoalphalipoproteinemia, primary, 1; Tangier disease | 2021-10-19 | criteria provided, single submitter | clinical testing |